Hong Kong · Delayed Price · Currency is HKD Innovent Biologics Statistics
Total Valuation
HKG:1801 has a market cap or net worth of HKD 153.13 billion. The enterprise value is 135.98 billion.
| Market Cap | 153.13B |
| Enterprise Value | 135.98B |
Important Dates
The next estimated earnings date is Friday, August 21, 2026.
| Earnings Date | Aug 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:1801 has 1.74 billion shares outstanding. The number of shares has increased by 6.98% in one year.
| Current Share Class | 1.74B |
| Shares Outstanding | 1.74B |
| Shares Change (YoY) | +6.98% |
| Shares Change (QoQ) | +5.48% |
| Owned by Insiders (%) | 6.65% |
| Owned by Institutions (%) | 48.66% |
| Float | 1.61B |
Valuation Ratios
The trailing PE ratio is 168.73 and the forward PE ratio is 47.47.
| PE Ratio | 168.73 |
| Forward PE | 47.47 |
| PS Ratio | 10.55 |
| PB Ratio | 7.11 |
| P/TBV Ratio | 7.72 |
| P/FCF Ratio | 14.14 |
| P/OCF Ratio | 13.76 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 99.05, with an EV/FCF ratio of 12.56.
| EV / Earnings | 150.19 |
| EV / Sales | 9.37 |
| EV / EBITDA | 99.05 |
| EV / EBIT | 191.87 |
| EV / FCF | 12.56 |
Financial Position
The company has a current ratio of 2.62, with a Debt / Equity ratio of 0.15.
| Current Ratio | 2.62 |
| Quick Ratio | 2.38 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 2.12 |
| Debt / FCF | 0.29 |
| Interest Coverage | 9.22 |
Financial Efficiency
Return on equity (ROE) is 5.01% and return on invested capital (ROIC) is 18.05%.
| Return on Equity (ROE) | 5.01% |
| Return on Assets (ROA) | 1.56% |
| Return on Invested Capital (ROIC) | 18.05% |
| Return on Capital Employed (ROCE) | 2.53% |
| Weighted Average Cost of Capital (WACC) | 5.51% |
| Revenue Per Employee | 1.93M |
| Profits Per Employee | 120,680 |
| Employee Count | 7,502 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 2.87 |
Taxes
In the past 12 months, HKG:1801 has paid 28.22 million in taxes.
| Income Tax | 28.22M |
| Effective Tax Rate | 3.02% |
Stock Price Statistics
The stock price has increased by +68.42% in the last 52 weeks. The beta is 0.24, so HKG:1801's price volatility has been lower than the market average.
| Beta (5Y) | 0.24 |
| 52-Week Price Change | +68.42% |
| 50-Day Moving Average | 85.75 |
| 200-Day Moving Average | 89.06 |
| Relative Strength Index (RSI) | 50.56 |
| Average Volume (20 Days) | 11,524,446 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1801 had revenue of HKD 14.51 billion and earned 905.34 million in profits. Earnings per share was 0.52.
| Revenue | 14.51B |
| Gross Profit | 11.13B |
| Operating Income | 816.38M |
| Pretax Income | 933.56M |
| Net Income | 905.34M |
| EBITDA | 1.46B |
| EBIT | 816.38M |
| Earnings Per Share (EPS) | 0.52 |
Balance Sheet
The company has 20.29 billion in cash and 3.13 billion in debt, with a net cash position of 17.15 billion or 9.89 per share.
| Cash & Cash Equivalents | 20.29B |
| Total Debt | 3.13B |
| Net Cash | 17.15B |
| Net Cash Per Share | 9.89 |
| Equity (Book Value) | 21.54B |
| Book Value Per Share | 12.42 |
| Working Capital | 15.16B |
Cash Flow
In the last 12 months, operating cash flow was 11.13 billion and capital expenditures -300.33 million, giving a free cash flow of 10.83 billion.
| Operating Cash Flow | 11.13B |
| Capital Expenditures | -300.33M |
| Depreciation & Amortization | 664.14M |
| Net Borrowing | -58.45M |
| Free Cash Flow | 10.83B |
| FCF Per Share | 6.24 |
Margins
Gross margin is 76.66%, with operating and profit margins of 5.63% and 6.24%.
| Gross Margin | 76.66% |
| Operating Margin | 5.63% |
| Pretax Margin | 6.43% |
| Profit Margin | 6.24% |
| EBITDA Margin | 10.05% |
| EBIT Margin | 5.63% |
| FCF Margin | 74.62% |
Dividends & Yields
HKG:1801 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.98% |
| Shareholder Yield | -6.98% |
| Earnings Yield | 0.59% |
| FCF Yield | 7.07% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:1801 has an Altman Z-Score of 3.93 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.93 |
| Piotroski F-Score | 6 |